Article

Antiremodelling Efficacy and Clinical Safety of Zofenopril in Patients with Grade 1and 2 Hypertension

Gulnoz KhamidullaevaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanTashkent, UzbekistanThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanGuzal AbdullaevaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanLola KhafizovaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanNigora SrojidinovaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanNigora TursunovaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanDilorom KurbanovaNodira Shakirova

International Journal of Biomedicinejournal2015en

ABI

Abstract

Objective: to estimate the antihypertensive, antiremodelling efficacy and clinical tolerability of the monotherapy with Zofenopril in patients with Grade 1 and 2 hypertension (HT 1 and 2)

Topics

Cardiovascular Health and Disease Prevention Blood Pressure and Hypertension Studies Heart Rate Variability and Autonomic Control

Identifiers

DOI: 10.21103/article5(4)_oa6

Citations and references

Cited by 09 references

Metrics — AkademScholar · Coming soon